Comparative Efficacy Of Imatinib, Dasatinib And Nilotinib For Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (Cml-Cp)- A Meta-Analysis And Indirect Comparison
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1037
https://www.valueinhealthjournal.com/article/S1098-3015(15)03113-7/fulltext
Title :
Comparative Efficacy Of Imatinib, Dasatinib And Nilotinib For Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (Cml-Cp)- A Meta-Analysis And Indirect Comparison
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03113-7&doi=10.1016/j.jval.2015.09.1037
First page :
A433
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
541